OBJECTIVE
To select characteristic endogenous metabolites in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients and to identify their molecular mechanism and potential clinical value.
METHODS
An ultra performance liquid chromatography and linear trap quadrupole-Orbitrap XL-mass